Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.370
-0.010 (-0.30%)
At close: Mar 13, 2026, 4:00 PM EDT
3.470
+0.100 (2.97%)
After-hours: Mar 13, 2026, 7:51 PM EDT

Ironwood Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5505507101,7891,9081,889
Market Cap Growth
112.00%-22.57%-60.32%-6.27%1.01%3.28%
Enterprise Value
931.85728.921,2172,2091,6651,625
Last Close Price
3.373.374.4311.4412.3911.66
PE Ratio
22.7122.47443.00-1.7712.913.63
Forward PE
2.507.8413.4214.1411.248.43
PEG Ratio
---1.982.251.21
PS Ratio
1.861.862.024.044.654.57
PB Ratio
--2.10-2.36-5.172.933.12
P/TBV Ratio
-2.10-2.10-2.35-5.133.543.16
P/FCF Ratio
4.334.336.869.776.977.22
P/OCF Ratio
4.334.336.859.756.977.21
EV/Sales Ratio
3.152.463.464.994.063.93
EV/EBITDA Ratio
7.727.2612.80-2.346.616.95
EV/EBIT Ratio
7.857.4013.07-2.346.657.00
EV/FCF Ratio
7.345.7411.7712.066.096.21
Debt / Equity Ratio
-1.51-1.51-1.98-1.480.630.59
Debt / EBITDA Ratio
5.965.966.30-0.761.652.04
Debt / FCF Ratio
4.714.715.803.911.521.82
Net Debt / Equity Ratio
-1.46-1.46-1.70-1.80-0.37-0.24
Net Debt / EBITDA Ratio
3.813.815.37-0.66-0.95-0.62
Net Debt / FCF Ratio
3.013.014.943.40-0.88-0.55
Asset Turnover
0.790.790.860.560.370.49
Quick Ratio
1.081.084.390.8030.234.54
Current Ratio
1.131.134.690.8430.584.61
Return on Equity (ROE)
-41.21%-41.21%-40.00%-564.93%52.42%-38.03%
Return on Assets (ROA)
43.65%43.65%45.01%-109.72%29.37%-17.45%
Return on Invested Capital (ROIC)
88.50%88.50%69.52%-237.06%73.64%-46.42%
Return on Capital Employed (ROCE)
42.21%42.21%36.73%-148.89%24.54%31.13%
Earnings Yield
4.37%4.45%0.23%-56.38%7.75%27.53%
FCF Yield
23.11%23.11%14.57%10.24%14.34%13.85%
Buyback Yield / Dilution
-0.04%-0.04%-1.45%-0.36%6.12%0.24%
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q